Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy.

Thomas, Anita; Vanthoor, Joren; Vos, Gigi; Tsaur, Igor; Albersen, Maarten

Thomas, Anita; Vanthoor, Joren; Vos, Gigi; Tsaur, Igor; Albersen, Maarten.

Afiliação

Thomas A; Department of Urology and Pediatric Urology, Mainz University Medicine, Mainz, Germany.
Vanthoor J; Department of Urology, University Hospitals, Leuven, Belgium.
Vos G; Department of Urology, University Hospitals, Leuven, Belgium.
Tsaur I; Department of Urology and Pediatric Urology, Mainz University Medicine, Mainz, Germany.
Albersen M; Department of Urology, University Hospitals, Leuven, Belgium.

Curr Opin Urol ; 30(2): 202-207, 2020 03.

Article em En | MEDLINE | ID: mdl-31895076

Assuntos

Neoplasias Penianas/genética; Neoplasias Penianas/terapia; Anticorpos Monoclonais Humanizados/uso terapêutico; Antineoplásicos/uso terapêutico; Humanos; Masculino; Mutação; Neoplasias Penianas/etiologia; Prognóstico; Quinazolinonas/uso terapêutico; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google